The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMM27M, a humanized Fc-engineered anti CTLA-4 antibody, in patients with advanced solid tumors: A phase I dose-escalation and dose-expansion study.
 
Qiufan Zheng
No Relationships to Disclose
 
Shusen Wang
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Pfizer
 
Quanli Gao
No Relationships to Disclose
 
Qingyuan Zhang
No Relationships to Disclose
 
Shikai WU
No Relationships to Disclose
 
Zhihua Li
No Relationships to Disclose
 
Li Enxiao
No Relationships to Disclose
 
Zhen Wang
No Relationships to Disclose
 
Benquan Sun
No Relationships to Disclose
 
Deqiang Jing
No Relationships to Disclose
 
Qiying Lu
Leadership - ImmuneOnco Biopharmaceuticals
 
Wenzhi Tian
Leadership - ImmuneOnco Biopharmaceuticals
Stock and Other Ownership Interests - ImmuneOnco Biopharmaceuticals